Compare PD & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PD | ETON |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2019 | 2018 |
| Metric | PD | ETON |
|---|---|---|
| Price | $15.59 | $55.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $12.64 | ★ $71.00 |
| AVG Volume (30 Days) | ★ 1.4M | 480.3K |
| Earning Date | 11-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 416.95 | N/A |
| EPS | 0.19 | ★ 0.41 |
| Revenue | ★ $492,546,000.00 | $79,950,000.00 |
| Revenue This Year | $0.35 | $88.01 |
| Revenue Next Year | $2.03 | $49.11 |
| P/E Ratio | ★ $82.00 | $126.78 |
| Revenue Growth | 5.36 | ★ 104.94 |
| 52 Week Low | $5.70 | $14.27 |
| 52 Week High | $16.77 | $66.37 |
| Indicator | PD | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 68.58 | 49.28 |
| Support Level | $6.08 | $53.60 |
| Resistance Level | N/A | $60.60 |
| Average True Range (ATR) | 0.54 | 3.48 |
| MACD | 0.01 | -0.68 |
| Stochastic Oscillator | 90.22 | 58.93 |
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.